Opposition pledges $100m for Victoria’s medical research institutes

By Rebecca Stone

Victoria’s state opposition has pledged an extra $100 million over four years for Victoria’s 14 independent medical research institutes if the Coalition wins the November election.

State Opposition Leader Jess Wilson was due to announce the plan Thursday. It remains a campaign pledge, not an appropriation, and the report sets out no eligibility rules, allocation shares or conditions of payment.

The stakes are visible in an estimate from the Australian Association of Medical Research Institutes (AAMRI): 10 of the 14 centres will be forced to close by 2030 if their finances do not improve. The estimate followed an SMH investigation that found “existential financial problems” across the sector.

The association provides no institute-by-institute cash-flow forecast, so the 10-centre figure functions as a sector projection rather than a measured closure count.

What has driven the funding crisis?

Years of flat federal funding for science have combined with sharp increases in the cost of research. Taxpayer-funded grants remain the financial lifeline of the institutes, but their value does not cover the work they support. Australia’s research spending as a share of GDP is also in long-term decline, even as other advanced economies invest more heavily in science.

In September, the Hudson Institute of Medical Research became the first of the 14 institutes to announce a structural change, revealing plans to merge with Monash University. People familiar with the Florey Institute of Neuroscience and Mental Health described its business plan as “doomed,” although the report did not identify those sources or provide a financial analysis of the institute.

That sequence does not prove every centre will close, but it makes the AAMRI forecast a planning issue rather than a remote scenario. The cited merger announcement provides no terms, staffing plan or research-portfolio changes, so continuity cannot be assessed from it.

For research managers, the immediate budget questions are operating cash and indirect-cost recovery, the institutional overheads that let laboratories continue research after a grant is awarded.

What would the $100 million change?

AAMRI has campaigned for the state government to raise annual support from $48 million to $95 million. Under Wilson’s proposal, the additional four-year payment would lift total state support to about $60 million a year, according to Michelle Marven, executive officer of AAMRI’s Victorian branch.

Marven said: “This will absolutely put us on the pathway to sustainability for the sector. We really welcome this announcement. It’s not the full amount we had been asking for, but it’s a step in the right direction.”

She added: “It will really help to address the financial pressures facing our institutes, and will provide really incredible additional support for the sector.”

The funding level remains below AAMRI’s $95 million request, and neither the pledge nor Marven’s figures explain how the annual profile would operate across four years. For directors, that leaves the cash horizon, application timetable and treatment of multi-year commitments unresolved.

Wilson framed the injection in terms of the state’s research base: “Victoria must continue to be the medical research capital of Australia. But after 12 years of Labor, the industry is at risk of losing its brightest minds, highly skilled jobs, and the investment that should be coming to Victoria.”

Opposition health spokeswoman Georgie Crozier said: “Labor’s failure to provide long-term funding certainty is putting this industry and the jobs of the future at risk.” The political argument therefore rests on predictability as much as on the proposed sum.

Does current support close the gap?

Burnet Institute director Brendan Crabb said in September: “It is a high-priority, highly valued sector.” He diagnosed the constraint this way: “What we have is an underfunded, short-term, fragmented funding system that does not match that attitude.”

The Victorian government has already increased institute funding by $24.6 million over two years, Medical Research Minister Anthony Carbines said in September. He said the resulting program would provide more than $47.7 million for research indirect costs in 2025-26.

Carbines described that as “the largest amount of funding for research indirect costs provided by any Australian state or territory, in absolute terms.”

He added: “We will continue to support our medical research sector and continue to work with stakeholders and the Association of Australian Medical Research Institutes to advocate for a fairer share of medical research funding from the Commonwealth.”

AAMRI’s $48 million baseline and Carbines’ $47.7 million figure cover different reporting periods and are not presented as identical budget lines. The report gives no line-by-line reconciliation, so institute managers should not treat the two totals as interchangeable without a detailed funding schedule.

Carbines’ comparison is also absolute, not adjusted for population or number of institutes. It establishes the size of Victoria’s program, but not its intensity relative to another state’s support.

What should research managers watch?

The immediate decision point is the election result. If the Coalition wins, the $100 million becomes a budget commitment to negotiate; if it does not, the existing state program remains the stated policy baseline. AAMRI’s closure estimate and the planned Hudson-Monash merger make near-term cash flow, staffing and partner selection active portfolio questions.

The next test is whether a winning government publishes eligibility rules, annual allocations and multi-year grant terms, which would give institute directors the funding certainty they say they need.